MLchartDataset catalogue

personalized neoantigen peptide vaccine iNeo-Vac-P01

Term · Oncology and biomedicine · MLC-T-ONC-015981

A peptide-based, personalized cancer vaccine consisting of patient-specific mutated long peptides, which are immunogenic and unique to the patient's tumor, with potential immunomodulating and antineoplastic activities. Upon vaccination with the personalized neoantigen peptide vaccine iNeo-Vac-P01, the peptides stimulate the host immune system to mount a specific and potent cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the neoantigens, which results in tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-015981
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015981",
  "term": "personalized neoantigen peptide vaccine iNeo-Vac-P01",
  "field": "Oncology and biomedicine",
  "definition": "A peptide-based, personalized cancer vaccine consisting of patient-specific mutated long peptides, which are immunogenic and unique to the patient's tumor, with potential immunomodulating and antineoplastic activities. Upon vaccination with the personalized neoantigen peptide vaccine iNeo-Vac-P01, the peptides stimulate the host immune system to mount a specific and potent cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the neoantigens, which results in tumor cell lysis.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/personalized-neoantigen-peptide-vaccine-ineo-vac-p01/"
}

Record 13,021 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.